- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07916428
AI-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students (AI-T2DM-NS)
Developing an Artificial Intelligence-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students at Alexandria University
This study will develop and test an artificial intelligence (AI) model that estimates the risk of type 2 diabetes among senior (third- and fourth-year) nursing students at the Faculty of Nursing, Alexandria University, Egypt. Type 2 diabetes is common in Egypt, and many cases are not diagnosed. Daily habits such as diet, physical activity, and body weight play a major role in who develops it. Nursing students will become health care providers who teach patients about healthy living, so it is important to find those who may be at risk early.
About 200 students will take part. Each student will complete a questionnaire about personal information and the Health-Promoting Lifestyle Profile II, which measures health habits such as nutrition, physical activity, stress management, and health responsibility. The researcher will measure height, weight, waist size, and blood pressure. Each student's diabetes risk will be scored using the Arabic version of the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK), which classifies risk as low, moderate, or high.
These data will be used to build a machine learning model that predicts each student's diabetes risk level from lifestyle and body measurement factors, and shows which factors influenced the prediction most. Students will then try the model and rate how useful and easy to use it is.
No treatment or intervention will be given. The study aims to support early identification of students at risk and to provide a model that nursing education programs and community health nurses could use in preventive health efforts.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Dr. Mohamed Fakhry Ahmed Salem, PhD
- Numéro de téléphone: 01286038014
- E-mail: Mohamed.Fakhry@alexu.edu.eg
Lieux d'étude
-
-
-
Alexandria, Egypte, 21511
- Faculty of Nursing, Alexandria University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Third- and fourth-year (senior) undergraduate nursing students, male and female, enrolled at the Faculty of Nursing, Alexandria University, Egypt, who do not have diabetes or endocrine disorders affecting glucose metabolism and are not pregnant.
La description
Inclusion Criteria:
- Regularly enrolled third- or fourth-year (senior) undergraduate nursing students at the Faculty of Nursing, Alexandria University.
- Willing to provide written informed consent and participate voluntarily.
- Have access to an internet-enabled electronic device (smartphone, tablet, or computer) and basic digital literacy.
Exclusion Criteria:
- Previously diagnosed with type 1 or type 2 diabetes mellitus.
- Chronic endocrine disorders known to affect glucose metabolism.
- Pregnancy.
- Incomplete or invalid questionnaire responses.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_CONTROL
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Senior Nursing Students
Description: Stratified random sample of third- and fourth-year (senior) nursing students at the Faculty of Nursing, Alexandria University, who complete the questionnaires and anthropometric measurements, contribute data for developing the AI model, and then try the model and rate its usefulness and ease of use. |
A machine learning model developed from students' lifestyle (HPLP-II), anthropometric, and blood pressure data to predict type 2 diabetes risk level (low, moderate, high) and identify the most influential factors. Students will use the model once and rate its usefulness and ease of use. No treatment or lifestyle intervention is delivered |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Type 2 Diabetes Risk Level According to AUSDRISK
Délai: aseline (single assessment at data collection, up to 1 day per participant)
|
Proportion of senior nursing students classified as low risk (total score 4 or less), moderate risk (5 to 10), or high risk (11 or more) for developing type 2 diabetes, using the Arabic version of the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK). Total score ranges from 0 to 34; higher scores indicate higher risk. |
aseline (single assessment at data collection, up to 1 day per participant)
|
|
Performance of the AI-Based Diabetes Risk Prediction Model
Délai: Upon completion of data collection and model development (up to 6 months after study start)
|
Accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of the machine learning model in classifying students into low, moderate, or high AUSDRISK risk categories, assessed on a held-out test set. |
Upon completion of data collection and model development (up to 6 months after study start)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Health-Promoting Lifestyle Profile II (HPLP-II) Score
Délai: Baseline (single assessment at data collection)
|
Total and subscale scores (health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, stress management) of the 52-item Arabic HPLP-II, rated on a 4-point scale (1 = never to 4 = routinely). Higher scores indicate more frequent health-promoting behaviors. |
Baseline (single assessment at data collection)
|
|
Perceived Usefulness and Ease of Use of the AI Model
Délai: Immediately after the student uses the AI model (single assessment)
|
Scores on a 12-item questionnaire (6 items on perceived usefulness, 6 on perceived ease of use) rated on a 7-point scale (1 = strongly disagree to 7 = strongly agree). Higher scores indicate better perceived usefulness and ease of use. |
Immediately after the student uses the AI model (single assessment)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Dr. Mohamed Fakhry Ahmed Salem, Alexandria University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AU-20-6-242
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .